Hyperoxia synergistically increases TNF-alpha-induced interleukin-8 gene expression in A549 cells

Am J Physiol Lung Cell Mol Physiol. 2000 Feb;278(2):L253-60. doi: 10.1152/ajplung.2000.278.2.L253.

Abstract

Interleukin (IL)-8 is an important mediator of acute lung injury. Hyperoxia induces IL-8 production in some cell types, but its effect on IL-8 gene expression in respiratory epithelium is not well described. In addition, IL-8 gene expression resulting from the combined effects of hyperoxia and proinflammatory cytokines has not been well characterized. We treated cultured respiratory epithelial-like cells (A549 cells) with hyperoxia alone, tumor necrosis factor (TNF)-alpha alone, or the combination of TNF-alpha and hyperoxia and evaluated IL-8 gene expression. Hyperoxia alone had a minimal effect on IL-8 gene expression, and TNF-alpha alone increased IL-8 gene expression in a time-dependent manner. In contrast, the combination of TNF-alpha and hyperoxia synergistically increased IL-8 gene expression as measured by ELISA (TNF-alpha alone for 24 h = 769 +/- 89 pg/ml vs. hyperoxia + TNF-alpha for 24 h = 1, 189 +/- 89 pg/ml) and Northern blot analyses. Experiments involving IL-8 promoter-reporter assays, electromobility shift assays, and Western blot analyses demonstrated that hyperoxia augmented TNF-alpha-mediated activation of the IL-8 promoter by a nuclear factor (NF)-kappaB-dependent mechanism and increased the duration of NF-kappaB nuclear translocation after concomitant treatment with TNF-alpha. Additional reporter gene assays demonstrated, however, that increased activation of NF-kappaB does not fully account for the synergistic effect of hyperoxia and that the NF-IL-6 site in the IL-8 promoter is also required for the synergistic effect of hyperoxia. We conclude that hyperoxia alone has a minimal effect on IL-8 gene expression but synergistically increases IL-8 gene expression in the presence of TNF-alpha by a mechanism involving cooperative interaction between the transcription factors NF-kappaB and NF-IL-6.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Binding Sites / genetics
  • CCAAT-Enhancer-Binding Protein-delta
  • CCAAT-Enhancer-Binding Proteins*
  • Cell Nucleus / metabolism
  • DNA-Binding Proteins / physiology
  • Gene Expression / drug effects*
  • Genes, Reporter / genetics
  • Humans
  • Hyperoxia / genetics*
  • Interleukin-8 / genetics*
  • Interleukin-8 / metabolism
  • Luciferases / genetics
  • Luciferases / metabolism
  • Mutation / physiology
  • NF-kappa B / metabolism
  • NF-kappa B / physiology
  • Nuclear Proteins / physiology
  • Plasmids
  • Promoter Regions, Genetic / drug effects
  • Promoter Regions, Genetic / genetics
  • Promoter Regions, Genetic / physiology
  • RNA, Messenger / metabolism
  • Transcription Factors*
  • Transfection
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • CCAAT-Enhancer-Binding Proteins
  • CEBPD protein, human
  • DNA-Binding Proteins
  • Interleukin-8
  • NF-kappa B
  • Nuclear Proteins
  • RNA, Messenger
  • Transcription Factors
  • Tumor Necrosis Factor-alpha
  • CCAAT-Enhancer-Binding Protein-delta
  • Luciferases